C21 Investments Inc. (CXXIF)
OTCMKTS · Delayed Price · Currency is USD
0.4050
+0.0114 (2.90%)
Oct 27, 2025, 3:52 PM EDT
C21 Investments Market Cap
C21 Investments has a market cap or net worth of $50.52 million as of October 28, 2025. Its market cap has increased by 81.25% in one year.
Market Cap
50.52M
Enterprise Value
60.48M
Revenue
32.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.41
Market Cap Chart
Since September 7, 1988, C21 Investments's market cap has increased from 6.40M to 50.52M, an increase of 689.46%. That is a compound annual growth rate of 5.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 45.41M | 87.69% |
| Dec 31, 2024 | 24.20M | -16.82% |
| Dec 29, 2023 | 29.09M | 26.13% |
| Dec 30, 2022 | 23.06M | -61.60% |
| Dec 31, 2021 | 60.05M | -59.92% |
| Dec 31, 2020 | 149.82M | 219.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |